These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24496334)

  • 1. Changes of natriuretic peptides concentration in early phase of acute myocardial infarction.
    Mujarić E; Prnjavorac B; Kalajdžija-Cero M; Šestić H; Rošić A; Sejdinović R; Mustafić S; Mehmedović A
    Med Glas (Zenica); 2014 Feb; 11(1):7-12. PubMed ID: 24496334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function.
    Mayr A; Mair J; Schocke M; Klug G; Pedarnig K; Haubner BJ; Nowosielski M; Grubinger T; Pachinger O; Metzler B
    Int J Cardiol; 2011 Feb; 147(1):118-23. PubMed ID: 19896736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
    Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.
    Rossetti E; Mariani M; Poli A; Palmerini T; Finazzi S; Lotzniker M; Sangiorgi D; De Servi S
    J Cardiovasc Med (Hagerstown); 2010 May; 11(5):359-64. PubMed ID: 20051875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
    Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Nekolla S; Vogt W; Schwaiger M; Schömig A; Kastrati A
    Am J Cardiol; 2006 Apr; 97(8):1151-6. PubMed ID: 16616017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.
    Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction].
    Ji L; Pei ZQ; Ma DF; Zhang J; Su JS; Gao XD; Xue WZ; Chen XP; Wang WS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Nov; 40(11):914-9. PubMed ID: 23363671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.